MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-MH-19-0026712
Altron Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹67.89 Lakh
▲ 28% YoY
Net profit · FY 2025
₹1.66 Lakh
Net margin 2.4%
EBITDA · FY 2025
₹5.64 Lakh
EBITDA margin 8.3%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
2
GST registered
About Altron Pharmaceuticals Private Limited
Data last updated:
Altron Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24299MH2020PTC350842. Its GSTIN is 27AAUCA4361K1Z5 (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Sumeet Hausila Prasad Dubey and Asha Hausila Prasad Dubey.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D3 245 Gorai Pritisangam Chsltdmuncipal R Wardgorai2 Rsc44Nrpragatischoolborivaliw, Mumbai, Maharashtra, India – 400092.
As per the financials filed for FY 2025, the company reported a revenue of ₹67.89 Lakh, a growth of 28% compared to the previous year. For the same year it recorded a net profit of ₹1.66 Lakh (net margin 2.4%) and EBITDA of ₹5.64 Lakh (EBITDA margin 8.3%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years.
Altron Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0026712). For more details, the company can be reached via its website altronpharma.com.
Company details
CIN U24299MH2020PTC350842
Registration Number 350842
Incorporation Date 27 November 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-19-0026712
Recognitions & Rankings of Altron Pharmaceuticals
Contact details
Altron Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is altronpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressD3 245 Gorai Pritisangam Chsltdmuncipal R Wardgorai2 Rsc44Nrpragatischoolborivaliw, Mumbai, Maharashtra, India – 400092
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Altron Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Altron Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Altron Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Altron Pharmaceuticals Private Limited, buy the company report.
Financials of Altron Pharmaceuticals Private Limited
FY 2025 filings availableAltron Pharmaceuticals Private Limited reported revenue of ₹67.89 Lakh (up 28% YoY) for FY 2025.
Revenue · FY 2025
₹67.89 Lakh ▲ 28%
Net profit · FY 2025
₹1.66 Lakh margin 2.4%
EBITDA · FY 2025
₹5.64 Lakh margin 8.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 28%
3 years · compounded
▲ 4%
EBITDA CAGR growth
1 year
▼ 28%
3 years · compounded
▲ 20%
Revenue has grown at a compounded annual rate (CAGR) of 4% over three years, including 28% growth in the latest year. EBITDA fell 28% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.64 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.66 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.3% | ||||
| Net Profit Margin | 2.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Altron Pharmaceuticals Private Limited, buy the company report.
Board of directors of Altron Pharmaceuticals Private Limited
Altron Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sumeet Hausila Prasad Dubey Also directs: Astron Hospitality LLP, Mediprime Healthcare Communication LLP | Director | 27 Nov 2020 | 5 Years 11 Months | Current |
| Asha Hausila Prasad Dubey | Director | 27 Nov 2020 | 5 Years 11 Months | Current |
Peer comparison
Altron Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Interferon Pharmaceuticals Private Limited | ₹68.04 Lakh (FY 2025) | 22.0% | Cooch Behar, West Bengal, India | |||
| Altron Pharmaceuticals Private Limitedthis company | ₹67.89 Lakh (FY 2025) | ₹1.66 Lakh | 2.4% | 28.0% | Mumbai, Maharashtra, India | |
| Amox Pharmaceuticals Private Limited | ₹67.7 Lakh (FY 2024) | 67.0% | Patna, Bihar, India | |||
| Waxemon Pharmaceuticals (OPC) Private Limited | ₹67.52 Lakh (FY 2025) | 2.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Altron Pharmaceuticals Private Limited, buy the company report.
Auditor
Altron Pharmaceuticals Private Limited is audited by Chirag J Mehta Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Chirag J Mehta Co | FY 2023 | 134959W |
Shareholding
The shareholding of Altron Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Altron Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Altron Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Altron Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Altron Pharmaceuticals Private Limited has 1 active EPFO establishment as of Mar 29, 2024.
Active EPFO establishments
1
GST
Altron Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAUCA4361K1Z5 | Maharashtra | Active | 06 Feb 2021 |
| 09AAUCA4361K1Z3 | Uttar Pradesh | Active | 02 Mar 2021 |
To see the full GST registrations and return filing status of Altron Pharmaceuticals Private Limited, buy the company report.
Recent activity
Altron Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Asha Hausila Prasad Dubey was appointed as Director on 27 Nov 2020.
AGM
Altron Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Altron Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Asha Hausila Prasad Dubey was appointed as Director.
Appointed
Sumeet Hausila Prasad Dubey was appointed as Director.
Incorporation
27 Nov 2020
Altron Pharmaceuticals Private Limited was registered on 27 Nov 2020 with Roc Mumbai & aged 5 years 11 months as per MCA records.
Frequently asked questions
Altron Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 November 2020 (6+ years old) and is registered under CIN U24299MH2020PTC350842.
Altron Pharmaceuticals has 2 current directors:
- Sumeet Hausila Prasad Dubey - Director
- Asha Hausila Prasad Dubey - Director
The latest financial statements of Altron Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Altron Pharmaceuticals is 27AAUCA4361K1Z5, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 09AAUCA4361K1Z3 (Uttar Pradesh).
The CIN (Corporate Identification Number) of Altron Pharmaceuticals is U24299MH2020PTC350842. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Altron Pharmaceuticals was incorporated on 27 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Altron Pharmaceuticals by revenue are Interferon Pharmaceuticals Private Limited, Amox Pharmaceuticals Private Limited, Waxemon Pharmaceuticals (OPC) Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Asha Hausila Prasad Dubey was appointed as Director on 27 Nov 2020. Sumeet Hausila Prasad Dubey was appointed as Director on 27 Nov 2020.
Yes, Altron Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0026712).
Altron Pharmaceuticals can be reached through the website altronpharma.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Altron Pharmaceuticals is at D3 245 Gorai Pritisangam Chsltdmuncipal R Wardgorai2 Rsc44Nrpragatischoolborivaliw, Mumbai, Maharashtra, India – 400092.